245 related articles for article (PubMed ID: 34151850)
1. Identification of Full-Length Wild-Type and Mutant Huntingtin Interacting Proteins by Crosslinking Immunoprecipitation in Mice Brain Cortex.
Sap KA; Guler AT; Bury A; Dekkers D; Demmers JAA; Reits EA
J Huntingtons Dis; 2021; 10(3):335-347. PubMed ID: 34151850
[TBL] [Abstract][Full Text] [Related]
2. Mutant Huntingtin Protein Interaction Map Implicates Dysregulation of Multiple Cellular Pathways in Neurodegeneration of Huntington's Disease.
Podvin S; Rosenthal SB; Poon W; Wei E; Fisch KM; Hook V
J Huntingtons Dis; 2022; 11(3):243-267. PubMed ID: 35871359
[TBL] [Abstract][Full Text] [Related]
3. Global Proteome and Ubiquitinome Changes in the Soluble and Insoluble Fractions of Q175 Huntington Mice Brains.
Sap KA; Guler AT; Bezstarosti K; Bury AE; Juenemann K; Demmers JA; Reits EA
Mol Cell Proteomics; 2019 Sep; 18(9):1705-1720. PubMed ID: 31138642
[TBL] [Abstract][Full Text] [Related]
4. Pathological polyQ expansion does not alter the conformation of the Huntingtin-HAP40 complex.
Huang B; Guo Q; Niedermeier ML; Cheng J; Engler T; Maurer M; Pautsch A; Baumeister W; Stengel F; Kochanek S; Fernández-Busnadiego R
Structure; 2021 Aug; 29(8):804-809.e5. PubMed ID: 33909994
[TBL] [Abstract][Full Text] [Related]
5. Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD rat.
Clemens LE; Weber JJ; Wlodkowski TT; Yu-Taeger L; Michaud M; Calaminus C; Eckert SH; Gaca J; Weiss A; Magg JC; Jansson EK; Eckert GP; Pichler BJ; Bordet T; Pruss RM; Riess O; Nguyen HP
Brain; 2015 Dec; 138(Pt 12):3632-53. PubMed ID: 26490331
[TBL] [Abstract][Full Text] [Related]
6. Mass Spectrometry Analysis of Wild-Type and Knock-in Q140/Q140 Huntington's Disease Mouse Brains Reveals Changes in Glycerophospholipids Including Alterations in Phosphatidic Acid and Lyso-Phosphatidic Acid.
Vodicka P; Mo S; Tousley A; Green KM; Sapp E; Iuliano M; Sadri-Vakili G; Shaffer SA; Aronin N; DiFiglia M; Kegel-Gleason KB
J Huntingtons Dis; 2015; 4(2):187-201. PubMed ID: 26397899
[TBL] [Abstract][Full Text] [Related]
7. Increased Steady-State Mutant Huntingtin mRNA in Huntington's Disease Brain.
Liu W; Chaurette J; Pfister EL; Kennington LA; Chase KO; Bullock J; Vonsattel JP; Faull RL; Macdonald D; DiFiglia M; Zamore PD; Aronin N
J Huntingtons Dis; 2013; 2(4):491-500. PubMed ID: 25062733
[TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis of wild-type and mutant huntingtin-associated proteins in mouse brains identifies unique interactions and involvement in protein synthesis.
Culver BP; Savas JN; Park SK; Choi JH; Zheng S; Zeitlin SO; Yates JR; Tanese N
J Biol Chem; 2012 Jun; 287(26):21599-614. PubMed ID: 22556411
[TBL] [Abstract][Full Text] [Related]
9. A series of N-terminal epitope tagged Hdh knock-in alleles expressing normal and mutant huntingtin: their application to understanding the effect of increasing the length of normal Huntingtin's polyglutamine stretch on CAG140 mouse model pathogenesis.
Zheng S; Ghitani N; Blackburn JS; Liu JP; Zeitlin SO
Mol Brain; 2012 Aug; 5():28. PubMed ID: 22892315
[TBL] [Abstract][Full Text] [Related]
10. Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage.
Kuhn A; Goldstein DR; Hodges A; Strand AD; Sengstag T; Kooperberg C; Becanovic K; Pouladi MA; Sathasivam K; Cha JH; Hannan AJ; Hayden MR; Leavitt BR; Dunnett SB; Ferrante RJ; Albin R; Shelbourne P; Delorenzi M; Augood SJ; Faull RL; Olson JM; Bates GP; Jones L; Luthi-Carter R
Hum Mol Genet; 2007 Aug; 16(15):1845-61. PubMed ID: 17519223
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.
Onur TS; Laitman A; Zhao H; Keyho R; Kim H; Wang J; Mair M; Wang H; Li L; Perez A; de Haro M; Wan YW; Allen G; Lu B; Al-Ramahi I; Liu Z; Botas J
Elife; 2021 Apr; 10():. PubMed ID: 33871358
[TBL] [Abstract][Full Text] [Related]
12. Polyglutamine tracts regulate beclin 1-dependent autophagy.
Ashkenazi A; Bento CF; Ricketts T; Vicinanza M; Siddiqi F; Pavel M; Squitieri F; Hardenberg MC; Imarisio S; Menzies FM; Rubinsztein DC
Nature; 2017 May; 545(7652):108-111. PubMed ID: 28445460
[TBL] [Abstract][Full Text] [Related]
13. Wild type Huntingtin reduces the cellular toxicity of mutant Huntingtin in mammalian cell models of Huntington's disease.
Ho LW; Brown R; Maxwell M; Wyttenbach A; Rubinsztein DC
J Med Genet; 2001 Jul; 38(7):450-2. PubMed ID: 11432963
[TBL] [Abstract][Full Text] [Related]
14. Mutant huntingtin interacts with {beta}-tubulin and disrupts vesicular transport and insulin secretion.
Smith R; Bacos K; Fedele V; Soulet D; Walz HA; Obermüller S; Lindqvist A; Björkqvist M; Klein P; Onnerfjord P; Brundin P; Mulder H; Li JY
Hum Mol Genet; 2009 Oct; 18(20):3942-54. PubMed ID: 19628478
[TBL] [Abstract][Full Text] [Related]
15. Mutant huntingtin and glycogen synthase kinase 3-beta accumulate in neuronal lipid rafts of a presymptomatic knock-in mouse model of Huntington's disease.
Valencia A; Reeves PB; Sapp E; Li X; Alexander J; Kegel KB; Chase K; Aronin N; DiFiglia M
J Neurosci Res; 2010 Jan; 88(1):179-90. PubMed ID: 19642201
[TBL] [Abstract][Full Text] [Related]
16. PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington's disease (HD).
Ratovitski T; Arbez N; Stewart JC; Chighladze E; Ross CA
Cell Cycle; 2015; 14(11):1716-29. PubMed ID: 25927346
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional profiles for distinct aggregation states of mutant Huntingtin exon 1 protein unmask new Huntington's disease pathways.
Moily NS; Ormsby AR; Stojilovic A; Ramdzan YM; Diesch J; Hannan RD; Zajac MS; Hannan AJ; Oshlack A; Hatters DM
Mol Cell Neurosci; 2017 Sep; 83():103-112. PubMed ID: 28743452
[TBL] [Abstract][Full Text] [Related]
18. Huntingtin structure is orchestrated by HAP40 and shows a polyglutamine expansion-specific interaction with exon 1.
Harding RJ; Deme JC; Hevler JF; Tamara S; Lemak A; Cantle JP; Szewczyk MM; Begeja N; Goss S; Zuo X; Loppnau P; Seitova A; Hutchinson A; Fan L; Truant R; Schapira M; Carroll JB; Heck AJR; Lea SM; Arrowsmith CH
Commun Biol; 2021 Dec; 4(1):1374. PubMed ID: 34880419
[TBL] [Abstract][Full Text] [Related]
19. Making (anti-) sense out of huntingtin levels in Huntington disease.
Evers MM; Schut MH; Pepers BA; Atalar M; van Belzen MJ; Faull RL; Roos RA; van Roon-Mom WM
Mol Neurodegener; 2015 Apr; 10():21. PubMed ID: 25928884
[TBL] [Abstract][Full Text] [Related]
20. CAG expansion affects the expression of mutant Huntingtin in the Huntington's disease brain.
Aronin N; Chase K; Young C; Sapp E; Schwarz C; Matta N; Kornreich R; Landwehrmeyer B; Bird E; Beal MF
Neuron; 1995 Nov; 15(5):1193-201. PubMed ID: 7576661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
